PubRank

D Middleton

Author PubWeight™ 133.72‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Should HLA mismatch acceptability for sensitized transplant candidates be determined at the high-resolution rather than the antigen level? Am J Transplant 2015 2.24
2 Comparative pathology of the diseases caused by Hendra and Nipah viruses. Microbes Infect 2001 2.21
3 Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. Tissue Antigens 2003 1.60
4 Mitochondrial DNA polymorphism: its role in longevity of the Irish population. Exp Gerontol 2001 1.58
5 Diagnostic PCR with Leishmania donovani specificity using sequences from the variable region of kinetoplast minicircle DNA. Trop Med Int Health 1999 1.58
6 Aggregates from mutant and wild-type alpha-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of beta-sheet and amyloid-like filaments. FEBS Lett 1998 1.55
7 Increased renal allograft thrombosis in CAPD patients. Nephrol Dial Transplant 1994 1.43
8 Reassessing the impact of donor HLA-C genotype on long-term liver transplant survival. Am J Transplant 2009 1.43
9 HLA class II typing of whole genome amplified mouth swab DNA. Tissue Antigens 2000 1.37
10 A community standard for immunogenomic data reporting and analysis: proposal for a STrengthening the REporting of Immunogenomic Studies statement. Tissue Antigens 2011 1.31
11 An international outbreak of salmonellosis associated with raw almonds contaminated with a rare phage type of Salmonella enteritidis. J Food Prot 2005 1.31
12 Report from the killer immunoglobulin-like receptor (KIR) anthropology component of the 15th International Histocompatibility Workshop: worldwide variation in the KIR loci and further evidence for the co-evolution of KIR and HLA. Tissue Antigens 2010 1.23
13 Association of functional heme oxygenase-1 gene promoter polymorphism with renal transplantation outcomes. Am J Transplant 2007 1.22
14 Common and well-documented HLA alleles: 2012 update to the CWD catalogue. Tissue Antigens 2013 1.22
15 Genetic polymorphism of IL-12 p40 gene in immune-mediated disease. Genes Immun 2000 1.21
16 HLA class I DNA typing of 215 "HLA-A, -B, -DR zero mismatched" kidney transplants. Tissue Antigens 1997 1.19
17 A DNA-RFLP typing system that positively identifies serologically well-defined and ill-defined HLA-DR and DQ alleles, including DRw10. Transplantation 1988 1.18
18 A common KIR2DS4 deletion variant in the human that predicts a soluble KIR molecule analogous to the KIR1D molecule observed in the rhesus monkey. Tissue Antigens 2002 1.16
19 Determinants of the geographical distribution of endemic giardiasis in Ontario, Canada: a spatial modelling approach. Epidemiol Infect 2004 1.15
20 Analysis of the distribution of HLA-B alleles in populations from five continents. Hum Immunol 2001 1.15
21 Mycoplasmas in cell cultures from rheumatoid synovial membranes. J Hyg (Lond) 1971 1.14
22 A descriptive analysis of giardiasis cases reported in Ontario, 1990-1998. Can J Public Health 2001 1.14
23 Duplication, mutation and recombination of the human orphan gene KIR2DS3 contribute to the diversity of KIR haplotypes. Genes Immun 2008 1.09
24 Association between polymorphism in regulatory region of gene encoding tumour necrosis factor alpha and risk of Alzheimer's disease and vascular dementia: a case-control study. Lancet 2001 1.08
25 The immunoglobulin M heavy chain constant region gene of the channel catfish, Ictalurus punctatus: an unusual mRNA splice pattern produces the membrane form of the molecule. Nucleic Acids Res 1990 1.07
26 Descriptive epidemiology of enteric illness for selected reportable diseases in Ontario, 2003. Can Commun Dis Rep 2006 1.04
27 Genetic diversity in the non-structural gene of parvovirus B19 detected by single-stranded conformational polymorphism assay (SSCP) and partial nucleotide sequencing. J Virol Methods 1995 1.04
28 Development of a PCR-SSOP approach capable of defining the natural killer cell inhibitory receptor (KIR) gene sequence repertoires. Tissue Antigens 2000 1.04
29 Survival of DNA HLA-DR typed and matched cadaver kidney transplants. The Collaborative Transplant Study. Lancet 1991 1.02
30 Increased frequencies of activating natural killer receptors are associated with liver injury in individuals who do not eliminate hepatitis C virus. Tissue Antigens 2007 1.02
31 Receptor systems controlling natural killer cell function are genetically stratified in Europe. Genes Immun 2009 1.01
32 Risk factors for Salmonella typhimurium DT104 and non-DT104 infection: a Canadian multi-provincial case-control study. Epidemiol Infect 2004 1.00
33 Determination of HLA-A, -C, -B, -DRB1 allele and haplotype frequency in Japanese population based on family study. Tissue Antigens 2015 0.98
34 Monocyte esterase? A factor involved in the pathogenesis of lymphoproliferative neoplasia. Leukemia 1987 0.98
35 KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations. Tissue Antigens 2007 0.98
36 Parvovirus B19 in kidney transplant patients. Transplantation 2000 0.95
37 High incidence of the Cys 282 Tyr mutation in the HFE gene in the Irish population--implications for haemochromatosis. Tissue Antigens 1998 0.95
38 Mismatched human leukocyte antigen alleles protect against heterosexual HIV transmission. J Acquir Immune Defic Syndr 2001 0.95
39 Immunoglobulin heavy chain variable region gene evolution: structure and family relationships of two genes and a pseudogene in a teleost fish. Proc Natl Acad Sci U S A 1988 0.94
40 Descriptive epidemiology of Lyme disease in Ontario: 1999-2004. Can Commun Dis Rep 2006 0.93
41 Structural relationship between the two IgY of the duck, Anas platyrhynchos: molecular genetic evidence. J Immunol 1992 0.93
42 Study of KIR genes in tuberculosis patients. Tissue Antigens 2006 0.93
43 Natural or raw almonds and an outbreak of a rare phage type of Salmonella enteritidis infection. Can Commun Dis Rep 2002 0.92
44 Analysis of the HLA population data (AHPD) submitted to the 15th International Histocompatibility/Immunogenetics Workshop by using the Gene[rate] computer tools accommodating ambiguous data (AHPD project report). Tissue Antigens 2010 0.92
45 Strategies to work with HLA data in human populations for histocompatibility, clinical transplantation, epidemiology and population genetics: HLA-NET methodological recommendations. Int J Immunogenet 2012 0.92
46 First identification of a ranavirus from green pythons (Chondropython viridis). J Wildl Dis 2002 0.92
47 HLA class I and II polymorphisms in Azores show different settlements in Oriental and Central islands. Tissue Antigens 2005 0.91
48 Signatures of natural selection and coevolution between killer cell immunoglobulin-like receptors (KIR) and HLA class I genes. Genes Immun 2010 0.91
49 HLA antigen frequency of Northern Ireland blood donors. Ulster Med J 1978 0.91
50 Analysis of killer immunoglobulin-like receptor genes in ankylosing spondylitis. Ann Rheum Dis 2008 0.90
51 Distribution of life cycle stages of Sarcoptes scabiei var wombati and effects of severe mange on common wombats in Victoria. J Wildl Dis 1999 0.90
52 16(th) IHIW: extending the number of resources and bioinformatics analysis for the investigation of HLA rare alleles. Int J Immunogenet 2012 0.89
53 Reocclusion prophylaxis with dipyridamole combined with acetylsalicylic acid following PTA. Angiology 1990 0.89
54 Pathogenesis studies with Australian bat lyssavirus in grey-headed flying foxes (Pteropus poliocephalus). Aust Vet J 2002 0.89
55 Frequencies of HLA-A, HLA-B, HLA-DR, and HLA-DQ phenotypes in the United Arab Emirates population. Tissue Antigens 2005 0.88
56 Preliminary analysis of a KIR haplotype estimation algorithm: a simulation study. Tissue Antigens 2007 0.88
57 Molecular analysis of HLA class I alleles in the Mexican Seri Indians: implications for their origin. Tissue Antigens 1999 0.88
58 Exploring implicit and explicit aspects of sense of agency. Conscious Cogn 2012 0.87
59 Osteochondrosis of the second cervical vertebra of a horse. Equine Vet J 2002 0.87
60 HLA genes in Portugal inferred from sequence-based typing: in the crossroad between Europe and Africa. Tissue Antigens 2005 0.87
61 Investigation of killer cell immunoglobulin-like receptor gene diversity, KIR2DL1 and KIR2DS1. Tissue Antigens 2008 0.87
62 Jejunal villous changes associated with farmer's lung. Postgrad Med J 1981 0.86
63 A study of the HLA-DR region in clinical subgroups of multiple sclerosis and its influence on prognosis. J Neurol Sci 1999 0.86
64 HL--A typing in Northern Ireland 1971-74. Ulster Med J 1975 0.86
65 Infection and disease in reservoir and spillover hosts: determinants of pathogen emergence. Curr Top Microbiol Immunol 2007 0.86
66 Heredofamilial deficiency of monocyte esterase in patients with rheumatoid arthritis. Ann Rheum Dis 1992 0.86
67 Ten-year results of renal transplantation with azathioprine and prednisolone as only immunosuppression. Lancet 1988 0.86
68 Allele resolution of HLA-A using oligonucleotide probes in a two-stage typing strategy. Tissue Antigens 1999 0.86
69 Putative immunoglobulin VH genes of the goldfish, Carassius auratus, detected by heterologous cross-hybridization with a murine VH probe. Vet Immunol Immunopathol 1986 0.85
70 Antibodies to lymphocytes and smooth muscle in the sera of patients with multiple sclerosis. Clin Immunol Immunopathol 1980 0.85
71 Mutation screening in exons 3 and 4 of alpha-synuclein in sporadic Parkinson's and sporadic and familial dementia with Lewy bodies cases. Neuroreport 1998 0.84
72 Using provincial client registries for selection of control subjects: lessons learned. Can Commun Dis Rep 2003 0.83
73 An interluekin 1B allele, which correlates with a high secretor phenotype, is associated with diabetic nephropathy. Cytokine 1998 0.83
74 Needlestick injuries during a mass vaccination campaign. Can J Public Health 1997 0.83
75 HLA antigen frequency in granuloma annulare. Br J Dermatol 1984 0.83
76 The influence of HLA-A, B, and DR matching on graft survival in primary cadaveric renal transplantation in Belfast. Transplantation 1985 0.83
77 Paraoxonase polymorphisms are not associated with cardiovascular risk in renal transplant recipients. Kidney Int 1999 0.82
78 Distribution of HLA-A alleles in eight ethnic groups from Pakistan. Tissue Antigens 2003 0.82
79 HLA-DR and DQ DNA genotyping in multiple sclerosis patients in Northern Ireland. Hum Immunol 1991 0.82
80 Analysis of HLA-DR matching in DNA-typed cadaver kidney transplants. Transplantation 1993 0.82
81 KIR receptors and HLA-C in the maintenance of pregnancy. Tissue Antigens 2007 0.82
82 HLA antigen frequencies and Wegener's granulomatosis. Clin Otolaryngol Allied Sci 1991 0.82
83 Sources of HLA typing sera. Ulster Med J 1978 0.82
84 No association of KIR3DL1 or KIR3DS1 or their alleles with ankylosing spondylitis. Tissue Antigens 2009 0.82
85 No impact of KIR-ligand mismatch on allograft outcome in HLA-compatible kidney transplantation. Am J Transplant 2013 0.82
86 Characterization of kinetoplast DNA minicircles of an Indian isolate of Leishmania donovani. Acta Trop 1999 0.81
87 'Immunogenetics of Aging': report on the activities of the 15th International HLA and Immunogenetics Working Group and 15th International HLA and Immunogenetics Workshop. Tissue Antigens 2011 0.81
88 A special report: histocompatibility testing guidelines for hematopoietic stem cell transplantation using volunteer donors. Tissue Antigens 1999 0.81
89 16(th) IHIW: population global distribution of killer immunoglobulin-like receptor (KIR) and ligands. Int J Immunogenet 2012 0.81
90 DNA HLA-DR typing results of 4000 kidney transplants. Transplantation 1993 0.81
91 Sparganosis in the monotremes Tachyglossus aculeatus and Ornithorhynchus anatinus in Australia. J Wildl Dis 1992 0.81
92 HLA-antigen frequencies in patients with a Plummer-Vinson stricture. Tissue Antigens 1978 0.81
93 Investigation of killer cell immunoglobulin-like receptor (KIR) gene diversity: KIR2DL2, KIR2DL5 and KIR2DS5. Tissue Antigens 2008 0.81
94 HLA antigen frequencies in flax byssinosis patients. Br J Ind Med 1979 0.81
95 Aldrin epoxidation kinetics in small samples of human liver. Biochem Pharmacol 1982 0.81
96 H.L.A. antigens in proliferative diabetic retinopathy. Int Ophthalmol 1981 0.81
97 Limited joint mobility in insulin-dependent diabetes: relationship to retinopathy, peripheral nerve function and HLA status. Q J Med 1985 0.80
98 Genetic, morphometric and immunohistochemical markers of latent coeliac disease. Eur J Gastroenterol Hepatol 1999 0.80
99 Letter: Influenza virus vaccination and renal transplant rejection. Br Med J 1974 0.80
100 The IL12B 3' untranslated region DNA polymorphism is not associated with early-onset type 1 diabetes. Genes Immun 2002 0.80
101 Genetic association studies of tumour necrosis factor alpha and beta and tumour necrosis factor receptor 1 and 2 polymorphisms across the clinical spectrum of multiple sclerosis. J Neurol 1999 0.79
102 The distribution of Anoplocephala perfoliata in the intestine of the horse and associated pathological changes. Vet Parasitol 1997 0.79
103 One thousand renal transplants at Belfast City Hospital: post-graft neoplasia 1968-1999, comparing azathioprine only with cyclosporin-based regimes in a single centre. Clin Transpl 2000 0.79
104 Mineralization of the supraspinatus tendon in dogs. J Am Vet Med Assoc 1990 0.79
105 Is the phenotypic combination A1B8Cw7DR3 a marker for male longevity? J Am Geriatr Soc 1994 0.79
106 Investigation of killer cell immunoglobulin-like receptor gene diversity III. KIR2DL3. Tissue Antigens 2004 0.79
107 Molecular typing of HLA class I and class II antigens in Indian kala-azar patients. Trop Med Int Health 1997 0.79
108 Characterisation of a novel HLA-A pseudogene, HLA-BEL, with significant sequence identity with a gorilla MHC class I gene. Tissue Antigens 1999 0.79
109 Investigation by bioassay of the efficacy of sodium hydroxide treatment on the inactivation of mouse-adapted scrapie. Biologicals 2006 0.79
110 Frequency and associations of HLA class II TaqI allogenotypes in the Northern Ireland population. Hum Immunol 1990 0.78
111 HLA-DR antigens associated with major genetic risk for late-onset Alzheimer's disease. Neuroreport 1997 0.78
112 Anilides related to substituted benzamides. Potential antipsychotic activity of N-(4-amino-5-chloro-2-methoxyphenyl)-1-(phenylmethyl)-4-piperidinecarboxamide. J Med Chem 1983 0.78
113 Risk for Alzheimer's disease in older late-onset cases is associated with HLA-DRB1*03. Neurosci Lett 1999 0.78
114 Development of PCR-SSOP for the identification of HLA-A*02 subtypes and determination of HLA-A*02 frequencies within different ethnic populations. Tissue Antigens 1997 0.78
115 Molecular variation at the HLA-A, B, C, DRB1, DQA1, and DQB1 loci in full heritage American Indians in Arizona: private haplotypes and their evolution. Tissue Antigens 2009 0.78
116 Cyclosporin associated gingival overgrowth in renal transplant recipients. Oral Dis 1999 0.77
117 Identification of HLA-DRw52 associated antigens using HLA class II allogenotyping. Tissue Antigens 1988 0.77
118 HLA-A towards a high-resolution DNA typing. Tissue Antigens 1998 0.77
119 16th International HLA and Immunogenetics Workshop (IHIW) Introduction. Int J Immunogenet 2012 0.77
120 Natural inactivation of a common HLA allele (A*2402) has occurred on at least three separate occasions. J Immunol 1997 0.77
121 Effect of a dCTP:dTTP pool imbalance on DNA replication fidelity in Friend murine erythroleukemia cells. Environ Mol Mutagen 2000 0.77
122 Baseline pharmacology, electrophysiology and pharmacokinetics of mexiletine. Acta Cardiol Suppl 1980 0.77
123 Cultured skin fibroblast cells derived from bluetongue virus-inoculated sheep and field-infected cattle are not a source of late and protracted recoverable virus. J Gen Virol 2006 0.77
124 A special report: histocompatibility testing guidelines for hematopoietic stem cell transplantation using volunteer donors. Quality Assurance and Donor Registries Working Groups of the World Marrow Donor Association. Hum Immunol 1999 0.77
125 HLA-A *2607: sequence of a novel A*26 subtype predicted by DNA typing which shares the MA2.1 epitope with A*02, B*57 and B*58. Tissue Antigens 1996 0.77
126 The influence of transforming growth factor-beta1 gene polymorphisms on the severity of gingival overgrowth associated with concomitant use of cyclosporin A and a calcium channel blocker. J Periodontol 2001 0.77
127 Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. Eur J Immunogenet 2003 0.77
128 Investigation of killer cell immunoglobulin-like receptor gene diversity V. KIR3DL2. Tissue Antigens 2004 0.77
129 Distribution of HLA alleles in Portugal and Cabo Verde. Relationships with the slave trade route. Ann Hum Genet 2002 0.77
130 DNA typing of 3500 cadaver kidney transplants does not confirm the "DR6 effect". Transplant Proc 1993 0.77
131 Aberrant splicing of intron 1 creates a novel null HLA-B*1501 allele. Tissue Antigens 1999 0.76
132 Identification of two novel alleles HLA-B*3569 and -B*4450 and confirmation of HLA-A*2631 in the Brazilian population. Tissue Antigens 2007 0.76
133 HLA-DR antigen association with proliferative diabetic retinopathy. Int Ophthalmol 1985 0.76
134 16(th) IHIW: immunogenetics of aging. Int J Immunogenet 2013 0.76
135 Frequency of HLA-DPB1 alleles, including a novel DPB1 sequence, in the Northern Ireland population. Hum Immunol 1992 0.76
136 Influence of the mu-chain C-terminal sequence on polymerization of immunoglobulin M. Immunology 1999 0.76
137 Immunoglobulin VH genes of the goldfish, Carassius auratus: a re-examination. Mol Immunol 1991 0.76
138 Prion-removal capacity of chromatographic and ethanol precipitation steps used in the production of albumin and immunoglobulins. Vox Sang 2006 0.76
139 The search for HLA-matched donors: a summary of HLA-A*, -B*, -DRB1/3/4/5* alleles and their association with serologically defined HLA-A, -B, -DR antigens. Tissue Antigens 1997 0.75
140 Identification of three novel alleles of HLA-DRB1 and HLA-A in the Brazilian population. Tissue Antigens 2007 0.75
141 Characterisation of a new HLA-B allele, HLA-B*0720, identified in the Cuban population. Tissue Antigens 2001 0.75
142 The application of DNA technology to tissue typing. Ulster Med J 1988 0.75
143 Improvements to HLA-B*27 testing. Tissue Antigens 1999 0.75
144 Characterization of HLA-B*3921 and confirmation of HLA-B*4415, two variant HLA-B alleles identified in the Omani population. Tissue Antigens 2000 0.75
145 Analysis of HLA antigen association with proliferative diabetic retinopathy. Br J Ophthalmol 1982 0.75
146 Distribution of properdin factor B and glyoxalase I (further genetic markers) in Northern Ireland. Ulster Med J 1988 0.75
147 Incidence of gunshot wounds at a county hospital following the Los Angeles riot and a gang truce. J Trauma 1994 0.75
148 HLA antigens in asymptomatic diabetes. A 10-year follow-up study of potential diabetes in pregnancy and gestational diabetes. Ulster Med J 1979 0.75
149 Detection of HLA-A*24 null alleles by DNA typing methods. Tissue Antigens 1998 0.75
150 AAHL also involved under PETS scheme. Aust Vet J 2000 0.75
151 Long-range PCR amplification as an alternative strategy for characterizing novel HLA-B alleles. Eur J Immunogenet 1996 0.75
152 Comparison of serological and DNA HLA-DR typing results for transplantation in Western Europe, Eastern Europe, North America and South America. Transpl Int 1994 0.75
153 Analysis of discrepancies between serologic and DNA-RFLP typing for HLA-DR in kidney graft recipients. Transplant Proc 1992 0.75
154 Are human platelet alloantigens (HPA) minor transplantation antigens in clinical bone marrow transplantation? Bone Marrow Transplant 2003 0.75
155 A new DQw1 associated antigen: HLA-DR'Br'. Tissue Antigens 1985 0.75
156 Identification of a new HLA-B allele, HLA-B*0708. Tissue Antigens 1997 0.75
157 Development of PCR-SSOP for HLA-A typing of bone marrow registry donors. Tissue Antigens 1997 0.75
158 The effect of complement variation on HLA-DR sera. Tissue Antigens 1984 0.75
159 Yellow fever vaccination. Lancet 1999 0.75
160 A new HLA-DRB1*11 allele (DRB1*1109) differing at codons 32, 34 and 37. Tissue Antigens 1994 0.75
161 A squamous cell carcinoma and an adenocarcinoma in Australian treefrogs. Aust Vet J 2004 0.75
162 Identification of a new HLA-B*55 allele, HLA-B*5503. Tissue Antigens 1996 0.75
163 HLA antigens and multiple sclerosis in Northern Ireland. Ir J Med Sci 1990 0.75
164 A novel HLA-B allele, HLA-B*1803. Tissue Antigens 1996 0.75
165 DYNAMIC PROGRAMMING, SEQUENTIAL ESTIMATION AND SEQUENTIAL DETECTION PROCESSES. Proc Natl Acad Sci U S A 1961 0.75
166 An allelic cluster of DQ alpha restriction fragments is associated with multiple sclerosis: evidence that a second haplotype may influence disease susceptibility. Hum Immunol 1989 0.75
167 Investigation of prion removal/inactivation from chromatographic gel. Vox Sang 2006 0.75
168 Studies on the transmembrane domain of phospholamban using rotational resonance and magic angle oriented sample spinning (MAOSS) NMR spectroscopy. Biochem Soc Trans 1998 0.75
169 Community standards: a new policy to ensure consistency and transparency in immunogenomics. Int J Immunogenet 2012 0.75
170 A study of paired cadaver kidney transplants. Ulster Med J 1984 0.75
171 Pre-transplantation immunological monitoring and graft survival in recipients of renal allografts. Clin Nephrol 1984 0.75
172 Sequence analysis of spontaneously-arising mutations at the aprt locus in wild-type and thymidine kinase-deficient Friend cells: evidence for strand slippage-misalignment mechanism in formation of deletions. Biochem Soc Trans 1997 0.75
173 Increased interleukin 2 receptor expression in post-gestational women: relationship to impaired glucose tolerance and islet cell antibodies in pregnancy. Autoimmunity 1990 0.75
174 HLA tissue typing and chronic vulval dystrophy. Br J Obstet Gynaecol 1984 0.75
175 Mismatching for HLA-A, -B antigens and renal graft survival. Clin Nephrol 1985 0.75
176 Childhood sigmoid volvulus. Ann Emerg Med 1984 0.75
177 HLA antigen frequency in erythema multiforme and in recurrent herpes simplex. Tissue Antigens 1983 0.75
178 Histocompatibility testing guidelines for hematopoietic stem cell transplantation using volunteer donors: report from The World Marrow Donor Association. Quality Assurance and Donor Registries Working Groups of the World Marrow Donor Association. Bone Marrow Transplant 1999 0.75
179 Frequency of human lymphocyte antigens in patients with brucellosis. J Infect 1988 0.75
180 Frequency of HLA-DRBr in renal patients awaiting transplantation. Transplantation 1988 0.75
181 Real-time RT-PCR for detection of equine influenza and its evaluation using samples from horses infected with A/equine/Sydney/2007 (H3N8). Aust Vet J 2011 0.75
182 An outbreak of Salmonella reactive arthritis in Northern Ireland. Ir J Med Sci 1989 0.75
183 The HLA-DR antigen frequency in Northern Ireland compared to the frequency in Bristol, Edinburgh and Eire. Tissue Antigens 1985 0.75
184 Live donor renal transplantation--the experience of the Belfast Renal Unit. Ir J Med Sci 1989 0.75
185 Application of an HLA-B PCR-SSOP typing method to a bone marrow donor registry. Bone Marrow Transplant 1997 0.75
186 HLA class II frequencies in celiac disease patients in the west of Ireland. Hum Immunol 1992 0.75
187 Analysis of rare HLA-DRB1-DQB1 haplotypes in kidney donors and recipients. Transplant Proc 1995 0.75
188 Increased incidence of IgM class smooth muscle antibody in patients after renal transplantation. Transplantation 1981 0.75
189 Descriptive epidemiology of verotoxin-producing E. coli reported in Ontario, 1996-2005. Can Commun Dis Rep 2007 0.75
190 DNA typing: an important step forward? Collaborative Transplant Study. Transpl Int 1992 0.75
191 Use of a tetanus toxoid marker to allow differentiation of infected from vaccinated poultry without affecting the efficacy of a H5N1 avian influenza virus vaccine. Vet Rec 2010 0.75
192 A new HLA-B51 allele, B*5107 in RCE55 detected and characterized by PCR-SSOP, cloning and nucleotide sequence determination. Tissue Antigens 1996 0.75
193 A novel approach to analysis of phage clones by reference strand mediated conformation analysis. Dis Markers 2000 0.75